Literature DB >> 17065692

Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.

Piya Ballani1, Michael T Tran, Maria D Navar, Mayer B Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17065692     DOI： 10.2337/dc06-1478

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  19 in total

1.  U-500 insulin as a component of basal bolus insulin therapy in type 2 diabetes.

Authors:  Jolene Brown Lowery; Amy C Donihi; Mary T Korytkowski
Journal:  Diabetes Technol Ther       Date:  2012-02-24       Impact factor: 6.118

Review 2.  Clinical use of U-500 regular insulin: review and meta-analysis.

Authors:  Sirimon Reutrakul; Kristen Wroblewski; Rebecca L Brown
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 3.  Effects of chronic hyperinsulinemia in insulin-resistant patients.

Authors:  Sergio Muntoni; Sandro Muntoni; Boris Draznin
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

Review 4.  Extreme insulin resistance: indications and approaches to the use of U-500 insulin in type 2 diabetes mellitus.

Authors:  Alexandria M Dailey; Lisa R Tannock
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

5.  Durability of glycemic control using U-500 insulin.

Authors:  Alexandria M Dailey; Jennifer A Gibert; Lisa R Tannock
Journal:  Diabetes Res Clin Pract       Date:  2011-11-15       Impact factor: 5.602

6.  Clinical efficacy and patient satisfaction with U-500 insulin use.

Authors:  Alexandria M Dailey; Sarah Williams; Deepa Taneja; Lisa R Tannock
Journal:  Diabetes Res Clin Pract       Date:  2010-03-11       Impact factor: 5.602

7.  Standard and Novel Treatment Options for Metabolic Syndrome and Diabetes Mellitus.

Authors:  Elliott M Groves; Katherine Yu; Nathan D Wong; Shaista Malik
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-11-15

8.  Application of PK/PD modeling and simulation to dosing regimen optimization of high-dose human regular U-500 insulin.

Authors:  Amparo de la Peña; Xiaosu Ma; Shobha Reddy; Fernando Ovalle; Richard M Bergenstal; Jeffrey A Jackson
Journal:  J Diabetes Sci Technol       Date:  2014-05-12

Review 9.  Insulin therapy for type 2 diabetes.

Authors:  Luigi F Meneghini
Journal:  Endocrine       Date:  2012-10-27       Impact factor: 3.633

10.  U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients.

Authors:  Mayer B Davidson; Maria D Navar; Diana Echeverry; Petra Duran
Journal:  Diabetes Care       Date:  2009-11-12       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.